PURCHASE ORDER

ANEON BRILLIENT, LLC - DIRECT 8(A) AWARD OF A 3-YEAR, FFP-TYPE PURCHASE ORDER TO EXPAND DEVELOPMENT AND MAINTENANCE OF OCP ANALYSIS-PLATFORM IPORTAL FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF TRANSLATIONAL SCI

PIID: 75F40124P00138
Effective Date: May 7, 2024End Date: Closed on May 6, 2025
Award $
$363K
Vendor
ANEON BRILLIENT, LLC
NAICS
518210

Key Details

Dollars Obligated
$362,821.29
Awarding Sub-Agency
Food and Drug Administration
NAICS Code
518210
Place of Performance
VA

Description

DIRECT 8(A) AWARD OF A 3-YEAR, FFP-TYPE PURCHASE ORDER TO EXPAND DEVELOPMENT AND MAINTENANCE OF OCP ANALYSIS-PLATFORM IPORTAL FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF TRANSLATIONAL SCI

Context & Analysis

Department of Health and Human Services obligated $362,821.29 to ANEON BRILLIENT, LLC for direct 8(a) award of a 3-year, ffp-type purchase order to expand development and maintenance of ocp analysis-platform iportal for the u.s. food and drug administration (fda), center for drug evaluatio. The award is classified under NAICS 518210 and issued as a purchase order contract. Performance is located in VA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 518210 — related awards are listed below.

Contractor Information

UEI: MS8HMAY331Q5

Stay Updated

Get notified about new opportunities matching your interests.

Related